Clifton LaDuane R.'s most recent trade in Zevra Therapeutics Inc was a trade of 11,000 Common Stock done at an average price of $7.9 . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 7.86 per share. | 13 Feb 2025 | 11,000 | 51,361 (0%) | 0% | 7.9 | 86,471 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 68,000 | 68,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 43,333 | 86,667 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 43,333 | 62,361 (0%) | 0% | - | Common Stock | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 34,000 | 34,000 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO & Treasurer | Purchase of securities on an exchange or from another person at price $ 6.77 per share. | 17 Jul 2024 | 2,000 | 18,469 (0%) | 0% | 6.8 | 13,540 | Common Stock |
| Zevra Therapeutics Inc | Clifton LaDuane R. | CFO, Secretary & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 130,000 | 130,000 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 4.95 per share. | 18 May 2023 | 2,000 | 13,053 (0%) | 0% | 5.0 | 9,900 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 4.95 per share. | 18 May 2023 | 689 | 13,742 (0%) | 0% | 4.9 | 3,410 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 4.94 per share. | 18 May 2023 | 51 | 11,053 (0%) | 0% | 4.9 | 252 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 10 Mar 2023 | 1,725 | 11,002 (0%) | 0% | 4.2 | 7,159 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 5.82 per share. | 13 Jan 2023 | 610 | 9,252 (0%) | 0% | 5.8 | 3,550 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 5.60 per share. | 13 Jan 2023 | 25 | 9,277 (0%) | 0% | 5.6 | 140 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 459,726 | 459,726 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 5.98 per share. | 30 Sep 2022 | 600 | 7,709 (0%) | 0% | 6.0 | 3,588 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 5.98 per share. | 30 Sep 2022 | 400 | 8,109 (0%) | 0% | 6.0 | 2,393 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 18 May 2022 | 1,200 | 6,440 (0%) | 0% | 5.0 | 5,999 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 83,486 | 83,486 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 8.29 per share. | 18 Nov 2021 | 510 | 5,240 (0%) | 0% | 8.3 | 4,228 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 9.38 per share. | 29 Sep 2021 | 215 | 4,730 (0%) | 0% | 9.4 | 2,017 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 8.59 per share. | 20 Sep 2021 | 935 | 4,515 (0%) | 0% | 8.6 | 8,028 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 9.10 per share. | 01 Sep 2021 | 230 | 3,580 (0%) | 0% | 9.1 | 2,094 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 82,423 | 82,423 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 14.11 per share. | 23 Jun 2021 | 75 | 3,350 (0%) | 0% | 14.1 | 1,058 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 9.85 per share. | 27 May 2021 | 150 | 3,275 (0%) | 0% | 9.9 | 1,478 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 26 Aug 2020 | 1,000 | 50,000 (0%) | 0% | 0.8 | 839 | Common Stock |
| Zevra Therapeutics Inc | R. LaDuane Clifton | CFO, Secretary & Treasurer | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 18 Aug 2020 | 2,000 | 49,000 (0%) | 0% | 0.7 | 1,390 | Common Stock |